Home / World / World Lifestyle / Archive by category Health & Medical (Page 16)

Archive by category Health & Medical

FSH-free versus FSH-primed Infertility Treatment of Women with Polycystic Ovary Syndrome using Biphasic in Vitro Maturation: a Randomized Clinical Trial

AMSTERDAM, July 10, 2024 (Korea Bizwire) – This randomized, controlled trial was conducted at a tertiary IVF center, Ho Chi Minh City, Vietnam. Between January 2023 and June 2023, 120 women were randomized. Eligible women were aged 18–37 years with polycystic ovarian syndrome (PCOS). After providing written informed consent, participants were randomized (1:1) to undergo [...]

Io Therapeutics, Inc., Presented Data from Studies of IRX4204, the Company’s Phase II Clinical Development Stage, Highly Selective Third Generation RXR Nuclear Receptor Agonist Compound, Supporting Its Potential Use for Prevention and Treatment of Normal Aging-related Neurodegeneration, Parkinson’s Disease, and Alzheimer’s Disease

SPRING, Texas, Jul. 9 (Korea Bizwire) — Io Therapeutics, Inc., presented today results from studies done on the potential for prevention and treatment of normal aging-related neurodegeneration, Parkinson’s disease (PD), and Alzheimer’s disease (AD), with its clinical stage experimental therapeutic RXR nuclear receptor agonist compound IRX4204. IRX4204 is a highly potent and highly selective, orally [...]

MedPro International Sponsors Medical Services to Over 300 Patients

SUNRISE, Florida, USA, July 09, 2024 (Korea Bizwire) – MedPro International, through its philanthropic Global Giving program, sponsored medical services to more than 300 patients at a one-day event in Loma in Biñan City, Philippines. Held at a local medical center, the event provided comprehensive care, including vital screenings, cardiac EKG tests, x-rays, urine analyses, and doctor [...]

Smith+Nephew is Trailblazing a New Path for Female Surgeons with its Orthopaedics for All Initiative; a First-of-its-kind Global Advisory Board

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and inspiring inclusion for individuals wishing to pursue a career in orthopaedic surgery. The disparity of women in the field of orthopaedic surgery compared to men is staggering. According [...]

Io Therapeutics, Inc., Announces Presentation of Data on Induction of Tumor Growth Inhibiting Anti-cancer Immune Responses in Multiple Types of Cancers by a IRX5010, a Novel Retinoic Acid Nuclear Receptor Agonist Compound

SPRING, Texas, Jul. 8 (Korea Bizwire) — Io Therapeutics, Inc., presented today results from studies done in breast, lung, colorectal, and prostate cancer models with the company’s newest anti-cancer compound IRX5010, an agonist of retinoic acid nuclear receptor gamma which was discovered in the company’s oncology drug program. The presentation titled “RAR Gamma Agonist Compounds [...]

KFSH&RC Achieves Remarkable 98% Survival Rate in 400 Robotic Cardiac Surgeries

RIYADH, Saudi Arabia, Jul. 4 (Korea Bizwire) — King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of today, 400 robotic cardiac surgeries have been performed with a [...]

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (Korea Bizwire) – Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. [...]

IVI RMA Global and Lavima Fertility Join Forces in Research in Fertility Treatments

VALENCIA, Spain and BRUSSELS, July 03, 2024 (Korea Bizwire) – Seeking alternatives to obtain oocytes without ovarian stimulation is a pioneering line of research in reproductive medicine. The inconveniences that the process of ovarian stimulation can generate are a current barrier for some women and couples who are considering starting a reproductive treatment. In fact, [...]

Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank

REGULATED INFORMATION INSIDE INFORMATION Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Mont-Saint-Guibert, Belgium – July 3, 2024, 12:30pm CET / 6:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea [...]

Olon Group Announces the Acquisition of GTP Bioways Group

MILAN, July 03, 2024 (Korea Bizwire) – GTP Bioways Group is a French company operating as Biotech CDMO (Contract Developing and Manufacturing Organisation), specialising in R&D Services, process development and production of mAbs, enzymes, proteins, nanodrugs, ADCs and F&F. GTP Bioways Group, with multiple locations across France, specializes in delivering comprehensive services to biopharmaceutical companies. From [...]